News

LeMaitre Vascular's Impressive Q3 2024 Performance Report

LeMaitre Vascular's Impressive Q3 2024 Performance Report

LeMaitre Vascular Shows Robust Growth in Q3 2024

BURLINGTON, Mass. – LeMaitre Vascular, Inc. (NASDAQ: LMAT), a leading provider of vascular devices and services, has reported exceptional results for the third quarter of 2024. The company’s strong performance demonstrates its commitment to innovation in the medical device sector, especially in the area of vascular surgery.

Financial Highlights for Q3 2024

In Q3 2024, LeMaitre Vascular achieved sales of $54.8 million, a 16% increase compared to the previous year. This organic growth reflects the company's increasing market presence and demand for its products.

The gross margin expanded to 67.8%, an increase of 280 basis points, attributed to effective price management strategies and enhanced manufacturing efficiencies. Operating income surged by 43% to $13.1 million, resulting in a solid operating margin of 24%.

Furthermore, earnings per diluted share rose significantly, landing at $0.49, marking a 46% increase compared to Q3 2023. The company also reported a cash increase of $10.8 million, bringing its total cash reserves to $123.9 million.

Key Growth Drivers

The company noted that the growth in sales was primarily driven by robust demand for grafts, patches, and carotid shunts, with respective increases of 24%, 13%, and 18%. Notably, sales in the Asia-Pacific region jumped 24%, while EMEA and the Americas saw sales increases of 22% and 12%, respectively.

Management's Insights and Future Outlook

George LeMaitre, Chairman and CEO, expressed optimism about the company's trajectory, emphasizing that 2024 is on track to deliver healthy sales and profit growth. The company has adjusted its guidance for the full year, anticipating an operating margin of 24%, compared to 19% in 2023.

Shareholder Returns and Repurchase Actions

In a show of commitment to its shareholders, LeMaitre has declared a quarterly dividend of $0.16 per share, with payment scheduled for December. Additionally, the Company has authorized a share repurchase program allowing the buyback of up to $50 million of its common stock, underscoring its confidence in long-term growth.

Conference Call and Additional Resources

Interested parties can join the conference call today at 5:00 PM ET. The live broadcast and replay will be available on the Company's website, giving investors further insights into LeMaitre's performance and future direction.

About LeMaitre Vascular

LeMaitre is dedicated to providing innovative devices, implants, and services for treating peripheral vascular diseases, a condition affecting over 200 million people globally. Their products are crucial for vascular surgeons aiming to improve patient outcomes.

Frequently Asked Questions

What are the main financial highlights reported by LeMaitre in Q3 2024?

LeMaitre reported sales of $54.8 million, a gross margin of 67.8%, and an operating income of $13.1 million, reflecting solid financial growth.

How did sales perform across different regions?

Sales in the Asia-Pacific region rose by 24%, EMEA by 22%, and the Americas by 12%, showcasing robust growth across key markets.

What steps is LeMaitre taking to return value to shareholders?

The company announced a quarterly dividend of $0.16 per share and is executing a share repurchase program up to $50 million.

What is the projected operating margin for LeMaitre in 2024?

The company anticipates an operating margin of 24% for the full year, adjusted from its previous guidance.

How can investors listen to the conference call?

The conference call will be available via live broadcast on the Company's website, with replays accessible shortly after.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 371

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 130

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 100

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 389

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 488

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 312

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading

Top 5 Most Recently Viewed Articles

Kochav Defense Offers Class A Shares for Independent Trading

Updated Category News Views 100

Kochav Defense Initiates Separate Trading of Class A Shares Kochav Defense Acquisition Corp. (NASDAQ: KCHVU) has exciting news for its investors! Starting July 21, 2025, holders of the unit shares sold during its initial public offering will have the option to trade their Class A ordinary shares and rights separately. This development is expected to provide additional...

Continue Reading
CITGO Takes Active Steps in Community Safety Drills

Updated Category News Views 234

CITGO Lake Charles Refinery completed a significant emergency response drill back in 2024, engaging over 130 participants including local, state, and federal emergency responders. This Worst-Case scenario drill simulated operations on the waterway to bolster command capabilities during potential environmental incidents. Emergency Preparedness: The Core of CITGO's...

Continue Reading
Exploring Premium REITs for Reliable Cash Flow Generation

Updated Category News Views 196

Understanding High-Yield REIT Investments Investing in high-yield real estate investment trusts (REITs) is a popular strategy for those seeking attractive dividend income. REITs are uniquely designed to channel income back to their shareholders, making them an appealing choice for generating passive income streams. This article will explore several high-yield REITs that...

Continue Reading
Orchestra BioMed Strengthens Board with Industry Veteran

Updated Category News Views 180

Introduction of Christopher Cleary to the Orchestra BioMed Board Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) is thrilled to announce a significant addition to its Board of Directors. Christopher Cleary, a monumental figure in the medical device industry, has joined the team as an independent member effective January 30, 2025. With over three decades of experience in...

Continue Reading
Microsoft's Latest Buyback Plan: What Investors Should Know

Updated Category News Views 202

Microsoft's Strategic Financial Moves Microsoft is making significant investments in its key areas while also ensuring it rewards its shareholders. As the tech giant ramps up its capital expenditures to improve cloud infrastructure—especially for artificial intelligence (AI)—it’s also keen on providing returns to its investors. Recently, the company announced a 10%...

Continue Reading